- Home
- VTS vs ABVX Comparison
VTS vs ABVX Comparison
Compare VTS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- ABVX
- Stock Information
- Founded
- VTS 2014
- ABVX 2013
- Country
- VTS United States
- ABVX France
- Employees
- VTS N/A
- ABVX N/A
- Industry
- VTS Oil & Gas Production
- ABVX
- Sector
- VTS Energy
- ABVX
- Exchange
- VTS Nasdaq
- ABVX Nasdaq
- Market Cap
- VTS 798.6M
- ABVX 722.3M
- IPO Year
- VTS N/A
- ABVX N/A
- Fundamental
- Price
- VTS $25.72
- ABVX $7.91
- Analyst Decision
- VTS Strong Buy
- ABVX Strong Buy
- Analyst Count
- VTS 1
- ABVX 6
- Target Price
- VTS $29.00
- ABVX $38.67
- AVG Volume (30 Days)
- VTS 141.6K
- ABVX 123.5K
- Earning Date
- VTS 11-04-2024
- ABVX 09-09-2024
- Dividend Yield
- VTS 8.09%
- ABVX N/A
- EPS Growth
- VTS N/A
- ABVX N/A
- EPS
- VTS 1.45
- ABVX N/A
- Revenue
- VTS $232,520,000.00
- ABVX $9,676,417.00
- Revenue This Year
- VTS $19.53
- ABVX $31.67
- Revenue Next Year
- VTS $0.87
- ABVX $1,189.66
- P/E Ratio
- VTS $17.95
- ABVX N/A
- Revenue Growth
- VTS 13.53
- ABVX 100.87
- 52 Week Low
- VTS $19.63
- ABVX $7.11
- 52 Week High
- VTS $28.41
- ABVX $17.02
- Technical
- Relative Strength Index (RSI)
- VTS 34.62
- ABVX 40.45
- Support Level
- VTS $27.00
- ABVX $7.11
- Resistance Level
- VTS $27.89
- ABVX $8.18
- Average True Range (ATR)
- VTS 0.61
- ABVX 0.44
- MACD
- VTS -0.28
- ABVX -0.00
- Stochastic Oscillator
- VTS 0.00
- ABVX 44.24
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.